91.80
+0.80
+(0.88%)
At close: January 16 at 3:18:48 PM GMT+3
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,896,886.62
2,705,508.12
2,334,112.28
2,144,143.11
2,045,031.62
Cost of Revenue
1,532,294.48
1,392,428.88
1,232,540.55
1,148,364.96
1,084,734.54
Gross Profit
1,364,592.14
1,313,079.24
1,101,571.74
995,778.15
960,297.08
Operating Expense
474,070.83
447,642.44
417,576.61
373,849.26
382,461.62
Operating Income
890,521.31
865,436.80
683,995.13
621,928.90
577,835.46
Net Non Operating Interest Income Expense
-26,080.66
-39,974.37
-22,305.02
-7,877.20
-12,643.29
Pretax Income
722,274.29
727,087.81
660,271.31
632,196.12
576,867.86
Tax Provision
39,824.40
38,699.07
27,583.65
21,734.76
15,241.95
Net Income Common Stockholders
658,087.34
657,687.91
599,305.26
578,161.35
528,157.03
Diluted NI Available to Com Stockholders
658,087.34
657,687.91
599,305.26
578,161.35
528,157.03
Basic EPS
3.29
3.29
3.00
2.89
2.64
Diluted EPS
3.29
3.29
3.00
2.89
2.64
Basic Average Shares
200,000.00
200,000.00
200,000.00
200,000.00
200,000.00
Diluted Average Shares
200,000.00
200,000.00
200,000.00
200,000.00
200,000.00
Total Operating Income as Reported
742,898.41
756,856.35
672,696.12
621,928.90
577,835.46
Rent Expense Supplemental
--
--
--
--
99.11
Total Expenses
2,006,365.31
1,840,071.33
1,650,117.16
1,522,214.22
1,467,196.16
Net Income from Continuing & Discontinued Operation
658,087.34
657,687.91
599,305.26
578,161.35
528,157.03
Normalized Income
806,760.96
768,425.83
616,584.41
578,176.33
527,770.37
Interest Income
9,399.76
6,482.14
575.34
321.85
1,396.10
Interest Expense
35,480.42
46,456.51
22,880.35
8,199.05
14,039.39
Net Interest Income
-26,080.66
-39,974.37
-22,305.02
-7,877.20
-12,643.29
EBIT
757,754.71
773,544.31
683,151.66
640,395.17
590,907.25
EBITDA
992,871.17
997,017.10
871,696.77
797,890.05
739,254.59
Reconciled Cost of Revenue
1,532,294.48
1,392,428.88
1,232,540.55
1,148,364.96
1,084,734.54
Reconciled Depreciation
235,116.46
223,472.78
188,545.11
157,494.88
148,347.34
Net Income from Continuing Operation Net Minority Interest
658,087.34
657,687.91
599,305.26
578,161.35
528,157.03
Total Unusual Items Excluding Goodwill
-157,349.48
-116,963.27
-18,032.48
-15.52
397.16
Total Unusual Items
-157,349.48
-116,963.27
-18,032.48
-15.52
397.16
Normalized EBITDA
1,150,220.65
1,113,980.36
889,729.24
797,905.57
738,857.43
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-8,675.86
-6,225.34
-753.33
-0.53
10.49
12/31/2020 - 2/22/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4009.SR Middle East Healthcare Company
74.90
+0.54%
4005.SR National Medical Care Company
158.00
-1.13%
4007.SR Al Hammadi Holding Company
41.70
0.00%
4018.SR Almoosa Health Company
140.80
-0.71%
4013.SR Dr. Sulaiman Al Habib Medical Services Group Company
291.20
-2.54%
4017.SR Dr. Soliman Abdel Kader Fakeeh
68.90
+0.15%
9518.SR Canadian General Medical Center Complex Company
7.00
+0.43%
2140.SR Ayyan Investment Company
16.16
+0.50%
4004.SR Dallah Healthcare Company
155.60
-0.13%
HWAIF Healwell AI Inc.
1.2400
0.00%